Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis

World Journal of Gastroenterology

Volumn 10, Issue 4, 2004, Pages 606-609

  Dong, Wei Guo ^a   Liu, Shao Ping ^a   Zhu, Hai Hang ^b   Luo, He Sheng ^a   Yu, Jie Ping ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANGELICA SINENSIS EXTRACT; ANTIGEN; ANTITHROMBOCYTIC AGENT; PADGEM PROTEIN; THROMBOXANE B2; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PROTEIN ANALYSIS; RADIOIMMUNOASSAY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; ULCERATIVE COLITIS; VASCULAR ENDOTHELIUM;

EID: 1542314887     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i4.606     Document Type: Article

References (44)

1. Jiang XL, Quan QZ, Liu T, Dong XC. Recent advances in research of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2000; 8: 216-218
2. Xia B. Etiology and pathogenesis of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2001; 6: 245-250
3. Kirsner JB. Historical origins of current IBD concepts. World J Gastroenterol 2001; 6: 175-184
4. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994; 106: 840-845
5. Collins CE, Rampton DS, Rogers J, Williams NS. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997; 9: 1213-1217
6. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis LE, Kouroumalis EA. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001; 96: 776-781
7. Mannaioni PF, Di Bello MG, Masini E. Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 1997; 46: 4-18
8. Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut 1993; 34: 247-251
9. Larsen TB, Nielsen JN, Fredholm L, Lund ED, Brandslund I, Munkholm P, Hey H. Platelets and anticoagulant capacity in patients with inflammatory bowel disease. Pathophysiol Haemost Thromb 2002; 32: 92-96
10. Van Bodegraven AA, Schoorl M, Baak JP, Linskens RK, Bartels PC, Tuynman HA. Hemostatic imbalance in active and quiescent ulcerative colitis. Am J Gastroenterol 2001; 96: 487-493
11. Collins CE, Rampton DS. Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut 1995; 36: 5-8
12. Collins CE, Rampton DS. Review article: platelets in inflammatory bowel disease - pathogenetic role and therapeutic implications. Aliment Pharmacol Ther 1997; 11: 237-247
13. Cui HF, Jiang XL. Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin. World J Gastroenterol 1999; 5: 448-450
14. Xu G, Tian KL, Liu GP, Zhong XJ, Tang SL, Sun YP. Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitis. World J Gastroenterol 2002; 8: 575-576
15. Jiang XL, Quart QZ, Wan ZK. Diagnosis, typing and therapy of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2000; 8: 332-334
16. Das KM, Farag SA. Current medical therapy of inflammatory bowel disease. World J Gastroenterol 2000; 6: 483-489
17. Rampton DS. Management of difficult inflammatory bowel disease: where are we now? World J Gastroenterol 2000; 6: 315-323
18. Rigat B, Reynaud D, Smiljanic-Georgijev N, Mahuran D. The GM2 activator protein, a novel inhibitor of platelet-activating factor. Biochem Biophys Res Commun 1999; 258: 256-259
19. Tyrrell DJ, Horne AP, Holme KR, Preuss JM, Page CP. Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv Pharmacol 1999; 46: 151-208
20. Xie L, Yang LH, Li XH. Resarch on the pharmacologic effects of Angelica Sinensis. Zhong Yiyao Yanjiu 2000; 16: 56-58
21. Zhang LF, Bian RL, Wei EQ. Effects of platelets on histamine release of mast cell and influence of sodium ferulate. Zhongguo Yaolixue Tongbao 1995; 11: 472-474
22. Sun Y, Lin AP, Zhang HQ, Bian RL. PAF-induced airway hyperresponsiveness and effects of sodium ferulate in guinea pigs. Zhongguo Yaolixue Tongbao 1996; 12: 518-520
23. Lin AP, Sun Y, Zhang HQ, Bian RL. Effects of sodium ferulate on platelets inummol activation-induced airway hyperresponsiveness. Liaoning Zhongyi Zazhi 1995; 22: 42-44
24. Zhou JY, Fan Y, Han ZF, Wu DZ, Hu ZB. Influence of ferulic acid sodium on the enhance of endothelial permeability induced by histamine. Zhongguo Yaolixue Tongbao 2000; 16: 664-666
25. Yi ZZ, Zhang LY, Xu LN. [The effect of Dang-Gui (Angelica sinensis) and its ingredient ferulic acid on rat platelet aggregation and release of 5-HT (author's transl)]. Yaoxue Xuebao 1980; 15: 321-326
26. Jones SC, Crabtree JE, Rembacken BJ,Dixon MF, Trejdosiewicz LK, Whicher JT, Axon AT. Musosal interleukIn-6 serection in ulcerative colitis: effects of anti-inflammatory drugs and T-cell stimulation. Scand J Gastroenterol 1994; 29: 722-728
27. Yu FW, Xiao GX, Fu WL, Yuan JC, Zhou LX, Qin XJ. Pathogenetic effects of platelet activating factor on enterogenic endotoxemia after burn. World J Gastroenterol 2000; 6: 451-453
28. Wu JX, Xu JY, Yuan YZ. Effect of emodin and sandostatin on metabolism of eicosanoids in acute necrotizing pancreatitis. World J Gastroenterol 2000; 6: 293-294
29. Nakamura T, Sakaguchi T, Unno N, Sugatani J, Miwa M, Nakamura S. Relationship between the platelet activating factor acetylhydrolase gene and intractability of ulcerative colitis. Dis Colon Rectum 2002; 45: 389-393
30. Vrij AA, Rijken J, Van Wersch JW, Stockbrugger RW. Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur J Clin Invest 2000; 30: 188-194
31. Harhaj NS, Barber AJ, Antonetti DA. Platelet-derived growth factor mediates tight junction redistribution and increases permeability in MDCK cells. J Cell Physiol 2002; 193: 349-364
32. Suzuki K, Sugimura K, Hasegawa K, Yoshida K, Suzuki A, Ishizuka K, Ohtsuka K, Honma T, Narisawa R, Asakura H. Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand J Gastroenterol 2001; 36: 1301-1306
33. Schaufelberger HD, Uhr MR, McGuckin C, Logan RP, Misiewicz JJ, Gordon-Smith EC, Beglinger C. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors. Eur J Clin Invest 1994; 24: 656-663
34. Danese S, de la Motte C, Sturm A, Vogel JD, West GA, Strong SA, Katz JA, Fiocchi C. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003; 124: 1249-1264
35. Fagerstam JP, Whiss PA, Strom M, Andersson RG. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES, in patients with inflammatory bowel disease. Inflamm Res 2000; 49: 466-472
36. Wang Z, Gao YH, Huang RS, Zhu GQ. Sodium ferulate is an inhibitor of thromboxane A2 synthetase. Zhongguo Yaoli Xuebao 1988; 9: 430-433
37. Gao SW, Chen ZJ. Effects of sodium ferulate on platelet aggregation and TX thromboxane A2 of platelet in patients with coronary heart disease. Zhongxiyi Jiehe Zazhi 1988; 8: 263-265
38. Liu SP, Dong WG, Wu DF, Luo HS, Yu JP, Mei Q. Effects of sodium ferulate on nitric oxide synthase and cyclooxygenase in colon of colitis rats. Zhongguo Yaolixue Tongbao 2003; 19: 571-574
39. Xu LN, Yu WG, Tian JY, Liu QY. Effects of sodium ferulate on arachidonic acid metabolism. Yaoxue Xuebao 1990; 25: 412-416
40. Carty E, Macey M, McCartney SA, Rampton DS. Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: antiinflammatory profile in inflammatory bowel disease. Aliment Pharmacol Ther 2000; 14: 807-817
41. 2 in human. Hubei Zhongyi Zazhi 2000; 22: 53-54
42. Cominacini L, Pasini A, Garbin U, Evangelista S, Crea AE, Tagliacozzi D, Nava C, Davoli A, LoCascio V. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species. Am J Hypertens 2002; 15 (10 Pt 1): 891-895
43. Zhang ZH, Yu SZ, Li GS, Zhao BL. Influence of sodium ferulate on human netrophil-derived oxygen metabolites. Zhongguo Yaolixue Tongbao 2001; 17: 515-517
44. Wang BH, Ouyng JP, Tu SZ, Wei L, Liu YM, Zheng HQ, Yang JW. Protective effect of Angelica Sinensis on human endothelial cells injury induced by high level of oxidized low-density lipoprotein in serum. Zhongguo Bingli Shengli Zazhi 2000; 16: 932